title: Prevention of phenytoin-induced gingival overgrowth by lovastatin in mice.
abstract: Drug-induced gingival overgrowth is caused by the antiseizure medication phenytoin, calcium channel blockers, and ciclosporin. Characteristics of these drug-induced gingival overgrowth lesions differ. We evaluate the ability of a mouse model to mimic human phenytoin-induced gingival overgrowth and assess the ability of a drug to prevent its development. Lovastatin was chosen based on previous analyses of tissue-specific regulation of CCN2 production in human gingival fibroblasts and the known roles of CCN2 in promoting fibrosis and epithelial to mesenchymal transition. Data indicate that anterior gingival tissue overgrowth occurred in phenytoin-treated mice based on gross tissue observations and histomorphometry of tissue sections. Molecular markers of epithelial plasticity and fibrosis were regulated by phenytoin in gingival epithelial tissues and in connective tissues similar to that seen in humans. Lovastatin attenuated epithelial gingival tissue growth in phenytoin-treated mice and altered the expressions of markers for epithelial to mesenchymal transition. Data indicate that phenytoin-induced gingival overgrowth in mice mimics molecular aspects of human gingival overgrowth and that lovastatin normalizes the tissue morphology and the expression of the molecular markers studied. Data are consistent with characterization of phenytoin-induced human gingival overgrowth in vivo and in vitro characteristics of cultured human gingival epithelial and connective tissue cells. Findings suggest that statins may serve to prevent or attenuate phenytoin-induced human gingival overgrowth, although specific human studies are required.
authors.affiliation: Department of Molecular and Cell Biology, Henry M. Golsman School of Dental Medicine, Boston University, Boston, Massachusetts.
authors.forename: Mohammad A
authors.initials: MA
authors.lastname: Assaggaf
authors.affiliation: Department of Applied Oral Sciences, Forsyth Institute, Cambridge, Massachusetts.
authors.forename: Alpdogan
authors.initials: A
authors.lastname: Kantarci
authors.affiliation: Department of Molecular and Cell Biology, Henry M. Golsman School of Dental Medicine, Boston University, Boston, Massachusetts.
authors.forename: Siddika S
authors.initials: SS
authors.lastname: Sume
authors.affiliation: Department of Molecular and Cell Biology, Henry M. Golsman School of Dental Medicine, Boston University, Boston, Massachusetts. Electronic address: trackman@bu.edu.
authors.forename: Philip C
authors.initials: PC
authors.lastname: Trackman
mesh_terms: D000594:Amino Acid Oxidoreductases / Q000378:metabolism; D000818:Animals; D015820:Cadherins / Q000378:metabolism; D055513:Connective Tissue Growth Factor / Q000378:metabolism; D005881:Gingiva / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D019214:Gingival Overgrowth / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D008148:Lovastatin / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D010672:Phenytoin; D016212:Transforming Growth Factor beta / Q000378:metabolism
chemical_list: D015820:Cadherins; D016212:Transforming Growth Factor beta; D055513:Connective Tissue Growth Factor; D010672:Phenytoin; D008148:Lovastatin; D000594:Amino Acid Oxidoreductases; C485601:Loxl2 protein, mouse
references.citation: J Periodontol. 1995 Jul;66(7):594-8
references.pmid: 7562351
references.citation: J Periodontol. 1995 May;66(5):345-50
references.pmid: 7623253
references.citation: Am J Kidney Dis. 1989 Apr;13(4):312-20
references.pmid: 2650539
references.citation: J Periodontol. 1989 Feb;60(2):104-12
references.pmid: 2786068
references.citation: J Oral Pathol Med. 1989 Apr;18(4):240-5
references.pmid: 2769597
references.citation: J Periodontol. 1996 May;67(5):463-71
references.pmid: 8724703
references.citation: J Clin Periodontol. 1996 Aug;23(8):730-6
references.pmid: 8877658
references.citation: Kidney Int. 1998 Apr;53(4):853-61
references.pmid: 9551391
references.citation: EMBO J. 2005 Oct 5;24(19):3446-58
references.pmid: 16096638
references.citation: Methods Find Exp Clin Pharmacol. 2006 Nov;28(9):627-56
references.pmid: 17200729
references.citation: J Biol Chem. 2007 May 25;282(21):15416-29
references.pmid: 17428796
references.citation: Transl Res. 2008 Jan;151(1):27-35
references.pmid: 18061125
references.citation: Am J Physiol Lung Cell Mol Physiol. 2007 Dec;293(6):L1427-36
references.pmid: 17951314
references.citation: J Periodontol. 2008 Jan;79(1):114-22
references.pmid: 18166100
references.citation: J Biol Chem. 2008 Apr 18;283(16):10835-47
references.pmid: 18287089
references.citation: J Allergy Clin Immunol. 2009 Aug;124(2):253-9, 259.e1-2
references.pmid: 19500825
references.citation: Arthritis Rheum. 2010 May;62(5):1523-32
references.pmid: 20213804
references.citation: Am J Pathol. 2010 Jul;177(1):208-18
references.pmid: 20489142
references.citation: Int J Oral Sci. 2009 Jun;1(2):90-8
references.pmid: 20687301
references.citation: Nat Med. 2010 Sep;16(9):1009-17
references.pmid: 20818376
references.citation: J Biol Chem. 2011 Jan 14;286(2):909-18
references.pmid: 21071451
references.citation: J Dent Res. 2011 Jul;90(7):887-93
references.pmid: 21483030
references.citation: EMBO Mol Med. 2011 Sep;3(9):528-44
references.pmid: 21732535
references.citation: Mol Cell. 2013 Dec 12;52(5):746-57
references.pmid: 24239292
references.citation: Periodontol 2000. 1999 Oct;21:176-96
references.pmid: 10551182
references.citation: Lab Invest. 1999 Dec;79(12):1655-67
references.pmid: 10616214
references.citation: Aust Dent J. 1999 Dec;44(4):219-32
references.pmid: 10687229
references.citation: J Clin Periodontol. 2000 Apr;27(4):217-23
references.pmid: 10783833
references.citation: J Periodontol. 2000 Jul;71(7):1117-20
references.pmid: 10960018
references.citation: J Periodontol. 2001 Jul;72(7):921-31
references.pmid: 11495141
references.citation: J Biol Chem. 2001 Dec 14;276(50):46707-13
references.pmid: 11590169
references.citation: Jpn J Cancer Res. 2002 Sep;93(9):1020-8
references.pmid: 12359056
references.citation: J Periodontal Res. 2002 Dec;37(6):412-5
references.pmid: 12472834
references.citation: Cancer Res. 2003 Apr 1;63(7):1657-66
references.pmid: 12670920
references.citation: Bioessays. 2003 May;25(5):452-63
references.pmid: 12717816
references.citation: Nat Med. 2003 Jul;9(7):964-8
references.pmid: 12808448
references.citation: Crit Rev Oral Biol Med. 2004;15(3):165-75
references.pmid: 15187034
references.citation: Dev Med Child Neurol. 1973 Aug;15(4):483-7
references.pmid: 4732898
references.citation: J Clin Periodontol. 1982 Sep;9(5):365-72
references.pmid: 6958684
references.citation: Acta Odontol Scand. 1982;40(5):353-7
references.pmid: 6960635
references.citation: J Clin Periodontol. 1983 May;10(3):237-46
references.pmid: 6575979
references.citation: Int J Cardiol. 1984 Feb;5(2):195-206
references.pmid: 6607894
references.citation: J Oral Pathol Med. 1990 Oct;19(9):404-7
references.pmid: 2176691
references.citation: Crit Rev Oral Biol Med. 1991;2(1):103-37
references.pmid: 1912141
references.citation: J Lipid Res. 1992 Nov;33(11):1569-82
references.pmid: 1464741
references.citation: Am J Pathol. 1993 Dec;143(6):1731-42
references.pmid: 8256859
references.citation: Scanning Microsc. 1993 Dec;7(4):1247-53
references.pmid: 8023091
references.citation: J Invest Dermatol. 1996 Apr;106(4):729-33
references.pmid: 8618012